Clinical Trial

TOUCHBBCA Joins the Carebox Connect Network

When We Tri(al) by TOUCH, The Black Breast Cancer Alliance has partnered with Carebox to provide Breasties, caregivers, and the…

12 months ago

SEQSTER Launches 1-Click Records™ for Healthcare & Life Sciences

Retrieve a Patient’s Longitudinal Health Record in Seconds to Confirm Study Eligibility & Query Population Cohorts via the Admin PortalSAN…

12 months ago

Prota Therapeutics US $21 Million Financing Led by SPRIM Global Investments

Financing advances development of Prota's peanut allergy remission therapy in preparation for a Phase 3 clinical trialMELBOURNE, AUSTRALIA / ACCESSWIRE…

12 months ago

Update Provided on GBB Drink Lab, Inc. Litigation and Safety Shot

TORONTO, ON / ACCESSWIRE / January 16, 2024 / FSD Pharma Inc. (NASDAQ:HUGE)(CSE:HUGE)(FRA:0K9A) ("FSD Pharma" or the "Company"), is a…

12 months ago

NightHawk’s Scorpius BioManufacturing Subsidiary Commences Work on Preclinical Program for New Client

Project reflects Scorpius’ versatility through its multi-functional biologics facility and expertise in microbial fermentationDURHAM, N.C., Jan. 16, 2024 (GLOBE NEWSWIRE)…

12 months ago

Solid Biosciences Granted FDA Orphan Drug Designation for Duchenne Muscular Dystrophy Gene Therapy Candidate SGT-003

– Patient dosing expected to begin mid-to-late Q1 2024 – CHARLESTOWN, Mass., Jan. 16, 2024 (GLOBE NEWSWIRE) -- Solid Biosciences…

12 months ago

Instil Bio Announces Strategic Update

DALLAS, Jan. 16, 2024 (GLOBE NEWSWIRE) -- Instil Bio, Inc. (“Instil” or the “Company”) (NASDAQ: TIL), a clinical-stage biopharmaceutical company…

12 months ago

PDS Biotech to Participate at B. Riley Securities 4th Annual Oncology Conference

PRINCETON, N.J., Jan. 16, 2024 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB) (“PDS Biotech” or “the Company”), a clinical-stage…

12 months ago

Oncotelic Therapeutics Announces Clinical Linkage of TGFB2 and IFNGR2 in Pediatric DMG Patients

AGOURA HILLS, Calif., Jan. 16, 2024 (GLOBE NEWSWIRE) -- Oncotelic Therapeutics, Inc (OTCQB:OTLC) announced today the peer reviewed publication of…

12 months ago